Join to View Full Profile
3800 Reservoir Rd NWWashington, DC 20007
Phone+1 202-444-2223
Fax+1 202-444-9429
Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 2014 - 2017
OtherClass of 2007
University of MinnesotaResidency, Internal Medicine
Certifications & Licensure
DC State Medical License 2017 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy Start of enrollment: 2020 Apr 16
- A Study to Investigate LYL797 in Adults With Solid Tumors Start of enrollment: 2022 Mar 29
Roles: Contact
- MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer Start of enrollment: 2024 Apr 15
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Discordant Response to Nivolumab Plus Ipilimumab and Identification ofV600E Mutation in Biphasic Malignant Pleural Mesothelioma: Case Report.Olivia Wilkins, Adedamola Omogbehin, Peter J Bergquist, Chul Kim, Stephen V Liu
JTO Clinical and Research Reports. 2025-05-01 - Shared decision making in routine oncology appointments with Black patients with lung cancer.Katarina E AuBuchon, Amanda Khoudary, Jennifer D Rodriguez, Osairys M Billini, Isabella Westervelt
Supportive Care in Cancer. 2025-03-05 - Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, Ryan Denu, Walid Macaron
Journal for Immunotherapy of Cancer. 2025-03-03
Press Mentions
Chemo-IO over IO Alone in Patients with Advanced NSCLCJuly 13th, 2021- Genomic Test in Lung Cancer: Waiting Is the Hardest PartJuly 6th, 2021
- What Did We Learn from IMpower010 in Resectable NSCLC?June 22nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
